Regression of Intracranial Meningiomas Following Treatment with Cabozantinib

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib

Recurrent meningiomas remain a substantial treatment challenge given the lack of effective therapeutic options aside from surgery and radiation therapy, which yield limited results in the retreatment situation. Systemic therapies have little effect, and responses are rare; the search for effective s...

Full description

Bibliographic Details
Main Authors: Rupesh Kotecha, Raees Tonse, Haley Appel, Yazmin Odia, Ritesh R. Kotecha, Guilherme Rabinowits, Minesh P. Mehta
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Current Oncology
Subjects:
meningioma
cabozantinib
VEGF
targeted therapy
Online Access:https://www.mdpi.com/1718-7729/28/2/145

Internet

https://www.mdpi.com/1718-7729/28/2/145

Similar Items